Chenxin Pharmaceuticals: Shareholder Chenxin Tongtai plans to reduce holdings by no more than 1%

Chenxin Pharmaceutical Announcement, shareholder Jiangsu Chenxin Tongtai Enterprise Management Co., Ltd. holds 1.37M shares of the company, accounting for 0.302%.
It plans to reduce no more than 1.37M shares, or 1% of its holdings, within three months after 15 trading days from the disclosure date, through centralized bidding or block trading.
The reduction period is from April 7, 2026, to July 7, 2026.
The source of shares is from the distribution of shares from Chenxin Technology Group’s spin-off.
The reason for the reduction is capital needs.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin